Last reviewed · How we verify
RSV-F Particle Vaccine
RSV-F Particle Vaccine is a Biologic drug developed by Novavax. It is currently in Phase 1 development.
At a glance
| Generic name | RSV-F Particle Vaccine |
|---|---|
| Sponsor | Novavax |
| Modality | Biologic |
| Phase | Phase 1 |
Approved indications
Common side effects
Key clinical trials
- A Study to Evaluate the Safety, Reactogenicity, and Immunogenicity of Adenovirus Serotype 26 Based Respiratory Syncytial Virus Pre-fusion (Ad26.RSV.Pre-F) Vaccine in RSV-Seronegative Toddlers 12 to 24 Months of Age (PHASE1, PHASE2)
- A Study to Evaluate the Safety and Immunogenicity of Seasonal Influenza Vaccine and an Adenovirus Serotype 26- Based Vaccine Encoding for the Respiratory Syncytial Virus Pre-fusion F Protein (Ad26.RSV.preF), With and Without Co-administration, in Adults Aged 60 Years and Older in Stable Health (PHASE2)
- Phase 1 Study to Evaluate the Safety and Immunogenicity of a Candidate Vaccine Against Respiratory Syncytial Virus (PHASE1)
- Phase I Study for SynGEM, an Intranasal Respiratory Syncytial Virus (RSV) Prefusion F Subunit Candidate Vaccine (PHASE1)
- RSV F Dose-Ranging Study in Women (PHASE2)
- Safety Study of Respiratory Syncytial Virus (RSV)-Fusion (F) Protein Particle Vaccine (PHASE1)
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |
Competitive intelligence
For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:
- RSV-F Particle Vaccine CI brief — competitive landscape report
- RSV-F Particle Vaccine updates RSS · CI watch RSS
- Novavax portfolio CI
Frequently asked questions about RSV-F Particle Vaccine
What is RSV-F Particle Vaccine?
RSV-F Particle Vaccine is a Biologic drug developed by Novavax.
Who makes RSV-F Particle Vaccine?
RSV-F Particle Vaccine is developed by Novavax (see full Novavax pipeline at /company/novavax).
What development phase is RSV-F Particle Vaccine in?
RSV-F Particle Vaccine is in Phase 1.
Related
- Manufacturer: Novavax — full pipeline
- Compare: RSV-F Particle Vaccine vs similar drugs
- Pricing: RSV-F Particle Vaccine cost, discount & access